Contact Us

Call Now:084 786 8888
blog-img

Most common cosmetic procedure performed in the United States?

Prime Inter­na­tion­al Jour­nal of Aes­thet­ic and Anti-age­ing med­i­cine

Bot­u­linum tox­in type A injec­tions are the most com­mon cos­met­ic pro­ce­dure per­formed in the Unit­ed States, with 4.3 mil­lion pro­ce­dures per­formed in 2015 account­ing for 42% of all cos­met­ic pro­ce­dures in that year, based on the Cos­met­ic Surgery Nation­al Data Bank Sta­tis­tics from the Amer­i­can Soci­ety for Aes­thet­ic Plas­tic Surgery, (ASAPS).

 Accord­ing to a new study pub­lished in the Aes­thet­ic Surgery Jour­nal, the offi­cial pub­li­ca­tion of ASAPS, patient sat­is­fac­tion with their over­all facial appear­ance increased by 28% with injec­tions to the so-called “11s” (the glabel­lar rhytids which are the lines that appear between the brows as we age). The sat­is­fac­tion rate was deter­mined based on par­tic­i­pat­ing patients’ com­ple­tion of the FACE-Q sur­vey, a new­ly devel­oped and val­i­dat­ed patient-report­ed out­come instru­ment that can be used for mea­sur­ing patient’s own per­cep­tions of cos­met­ic facial pro­ce­dures. The sur­vey con­sists of 63 ques­tions ask­ing patients to eval­u­ate their over­all appear­ance, age appear­ance, and the appear­ance of cheeks, nasolabi­al folds, low­er face and jaw­line, chin and neck.

Dr. Daniel C. Mills, Pres­i­dent of ASAPS states, “The results of this study are not sur­pris­ing and val­i­date what we’ve sus­pect­ed for quite some time. I see an ever-increas­ing influx of patients in my prac­tice in Lagu­na Beach, CA request­ing bot­u­linum tox­in type A injec­tions to the area between the brows and oth­er areas on the face like the crow’s feet and fore­head as a pre­ven­ta­tive anti-aging or, pre-aging mea­sure from patients in their 20s up to their 70s. It’s a quick non­sur­gi­cal fix that packs a pow­er­ful punch and this new study reaf­firms the effi­ca­cy of bot­u­linum tox­in type A and the sat­is­fac­tion it brings to patients,” he explains.

The study’s authors exam­ined 57 female patients who com­plet­ed the FACE-Q sur­vey. After the base­line sur­vey, the patients received injec­tions of one brand of bot­u­linum tox­in type A, (Botox, Dys­port or Xeomin) in the region between the brows. Two weeks post-injec­tion, the patients com­plet­ed the FACE-Q sur­vey again. The per­cent­age changes in patient respons­es from the first to sec­ond sur­veys were assessed to deter­mine how the injec­tions affect­ed patient sat­is­fac­tion with their facial appear­ance.

Patients stat­ed that they believe they look an aver­age of 5.6 years younger post-injec­tion with any of the bot­u­linum tox­in type A prod­ucts, (Botox, Dys­port and Xeomin). The aver­age age of the 57 patients with pre- and post-neu­ro­tox­in FACE-Q respons­es was 49.6 years (range of 32 – 75 years old)

Hugo Aesthetics author

At Hugo Aesthetics we know that looking good makes you feel great, confident and empowered. We mastered this art and invite you to indulge a little; you deserve it.


View All Post

Leave Comments